Re-inventing the biosensor
with Trinity Biotech

Native partnered with Trinity Biotech to develop a new, needle-free, Continuous Glucose Monitoring (CGM) system into an affordable, reusable and multi-sensor product. Now in the later stages of product development, CGM+ is a new AI-native system, combining multi-sensor data and real-time analytics to meet the evolving demands of AI-powered healthcare and wellness.

Unlike traditional CGMs focused solely on glucose monitoring, CGM+ integrates an ultra-thin, minimally invasive electrochemical glucose sensor with continuous monitoring of heart activity, body temperature and physical activity—all within a single, sleek and user-friendly modular wearable device. The innovative design utilises this technology to provide a solution that not only reduces the number of disposable components and waste, but also significantly lowers the cost of care compared to current leading market products.

The modular wearable has been designed and engineered for real-time insights - providing glucose, heart activity, temperature, and motion tracking in one seamless, sustainable platform. CGM+ has been engineered from the ground up to serve as a foundational platform for AI-native health application

As the device development progressed, Native also worked with Trinity to refine the value proposition and build investor confidence. Research and strategy activity was supported by marketing materials, a new website, social posts and an inspirational video - see below.